Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04518722 · ClinicalTrials.gov registry record
CT-Based Changes in Bone and Marrow Among Patients on Oral Steroids
A clinical trial of Asthma and Bone Density, Low, sponsored by University of Iowa.
- Recruiting
- Registry status
- 12
- Enrollment target
- 1
- Study location
NCT04518722: Recruiting study of Asthma and Bone Density, Low, sponsored by University of Iowa.
NCT04518722 is a study of Asthma and Bone Density, Low that is actively recruiting participants, run by University of Iowa. The registered enrollment target is 12 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04518722, a study of Asthma and Bone Density, Low, is actively recruiting participants, sponsored by University of Iowa.
- RECRUITING
- Registry status
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to assess the feasibility of emerging CT-based tools to measure changes in central and peripheral bone density, micro-structure, and marrow adipose tissue (MAT) among patients treated with oral steroids.
Primary Outcome
Marrow adipose tissue fraction at 14-16% location of the distal tibia from DECT ankle scans will be computed and compared between oral steroid and control groups.
Conditions Studied
Interventions
- RADIATION CT Scan
- RADIATION DXA Scan
- OTHER Steroid Intake Questionnaire
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2026-01 |
What NCT04518722 shows while recruiting
NCT04518722 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Asthma appearing as the primary indexed condition, and to 3 interventions - of which CT Scan is the first listed.
NCT04518722 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT04518722 about?
NCT04518722 is a clinical study titled "CT-Based Changes in Bone and Marrow Among Patients on Oral Steroids". The goal of this study is to assess the feasibility of emerging CT-based tools to measure changes in central and peripheral bone density, micro-structure, and marrow adipose tissue (MAT) among patients treated with oral steroids.
What is the current status of trial NCT04518722?
This trial is currently recruiting. The enrollment target is 12 participants. The study started on 2020-12-01. Estimated completion is 2026-01.
What conditions does trial NCT04518722 study?
This clinical trial studies the following conditions: Asthma, Bone Density, Low, Oral Steroid-Dependent Asthma (Disorder).
What interventions are being tested in trial NCT04518722?
The interventions under investigation include: CT Scan (RADIATION), DXA Scan (RADIATION), Steroid Intake Questionnaire (OTHER).
Who is sponsoring clinical trial NCT04518722?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04518722 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04518722's enrollment target sits among peer trials
12 360th of 374 higher than 9 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI